Cedars-Sinai Cancer investigators have found that Black men respond as well as white men to systemic therapies for advanced prostate cancer when access to quality health care is equal, regardless of socioeconomic status. Their study, published today in the peer-reviewed Journal of Clinical Oncology, counters previous research suggesting that Black men receiving these therapies—which include hormone therapy, chemotherapy and immunotherapy—fare worse than white men do.
from Medical Xpress - latest medical and health news stories https://ift.tt/El962Mu
